Talking to Your Kids About GLP-1 Medications: An Age-by-Age Guide

Wegovy (semaglutide) is FDA-approved for weight management in adolescents ages 12 and older. The STEP TEENS trial demonstrated meaningful weight loss and metabolic improvement in this age group. That means pediatricians and parents are now having conversations about GLP-1 medications with children and teenagers.

How you have that conversation matters enormously. Weight stigma in childhood can cause lasting psychological harm. But avoiding the conversation entirely — when a child's health is at risk — isn't responsible either. Here's how to navigate it.

The Clinical Context for Parents

Childhood obesity affects approximately 20% of children and adolescents in the United States. It's associated with type 2 diabetes, early cardiovascular disease, sleep apnea, joint problems, and significant psychological distress. For a subset of these young patients, lifestyle interventions alone aren't sufficient.

The STEP TEENS trial enrolled adolescents ages 12–17 with a BMI at or above the 95th percentile. Participants receiving semaglutide achieved an average BMI reduction of 16.1% compared to 0.6% with placebo. That's a clinically significant result.

However, pediatric GLP-1 prescribing should be approached with more caution than adult prescribing. Growth, puberty, bone development, and psychological development are all active processes that could potentially be affected by sustained appetite suppression and weight loss.

Ages 8–11: When a Parent Is Taking a GLP-1

At this age, kids notice. They see you injecting medication. They see you eating differently. They hear conversations. Here's how to explain it:

What to say: "I'm taking a medication that helps my body manage my weight better. It's prescribed by my doctor because my body needs some extra help in this area — just like some people need glasses to help their eyes or medicine to help their heart."

What not to say: "I'm taking pills to get skinny." "This medication makes me not hungry anymore." "Maybe when you're older you can take it too."

Key principles:

• Frame it as a health tool, not a cosmetic one
• Normalize medication for medical conditions without suggesting the child needs it
• Don't discuss weight loss numbers or body appearance goals
• Continue family meals and don't let your reduced appetite change the family eating environment

Ages 12–14: When Medication May Be Clinically Appropriate

If your child's pediatrician has raised the topic of GLP-1 medication, the conversation should be collaborative — involving the child, not happening about them.

What to say: "Dr. [Name] thinks a medication might help your body manage weight more effectively, alongside the diet and exercise changes we've been working on. This isn't because anything is wrong with you — it's because your body's metabolism works a certain way, and there's a medicine that can help."

Key principles:

• Include the teen in the decision-making process — forced medication undermines trust and adherence
• Discuss side effects openly and honestly, including nausea and injection discomfort
• Make clear this isn't a punishment or a judgment
• Focus on health outcomes (energy, sleep, blood sugar, joint pain) rather than appearance
• Address social concerns: "Will people at school know?" "Will I be different?"

Ages 15–17: Autonomy and Informed Consent

Older teens can and should be more involved in their medical decisions. By this age, they can understand clinical data, risk-benefit trade-offs, and long-term implications.

What to discuss:

• How the medication works (mechanism of action, at a level they can understand)
• What the clinical trials showed for their age group
• Side effects — be specific and honest, not reassuring to the point of inaccuracy
• The commitment involved: regular injections or daily pills, follow-up appointments, lab work
• What happens if they want to stop — including the weight regain data
• Privacy: who needs to know (doctor, pharmacist) and who doesn't (friends, extended family — that's their choice)

When to Push Back on a Pediatrician

Not every pediatric GLP-1 recommendation is appropriate. Consider pushing back or seeking a second opinion if:

• Your child hasn't tried supervised dietary and physical activity interventions first
• The BMI is borderline (just above the 95th percentile) with no weight-related comorbidities
• Your child has a history of disordered eating — GLP-1s can complicate eating disorder recovery
• The child is pre-pubertal — long-term effects during puberty are not well-studied
• The recommendation feels driven by appearance concerns rather than clinical indicators

Monitoring Is Non-Negotiable for Young Patients

Adolescent GLP-1 patients need closer monitoring than adults:

• Growth velocity tracking (are they still growing normally?)
• Pubertal development assessment at regular intervals
• Bone density screening if weight loss is rapid
• Nutritional labs every 3 months (B12, iron, vitamin D, calcium)
• Psychological well-being assessment — weight loss can paradoxically increase body image anxiety in teens
• Regular check-ins about social impact and peer relationships

This conversation doesn't have a script. Every child is different, every family dynamic is different, and every clinical situation is unique. But the framework remains the same: honesty, empowerment, medical accuracy, and absolutely no shame. If you can hit all four of those, you're doing it right.